Comerica Bank’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$193K Sell
4,682
-125
-3% -$4.94K ﹤0.01% 2316
2025
Q3
$179K Hold
4,807
﹤0.01% 2378
2025
Q2
$175K Hold
4,807
﹤0.01% 2372
2025
Q1
$186K Buy
4,807
+353
+8% +$14K ﹤0.01% 2332
2024
Q4
$169K Buy
4,454
+517
+13% +$20.6K ﹤0.01% 2387
2024
Q3
$165K Hold
3,937
﹤0.01% 2368
2024
Q2
$161K Sell
3,937
-1,250
-24% -$49.8K ﹤0.01% 2350
2024
Q1
$215K Sell
5,187
-250
-5% -$10.5K ﹤0.01% 2277
2023
Q4
$220K Hold
5,437
﹤0.01% 2213
2023
Q3
$213K Buy
+5,437
New +$216K ﹤0.01% 2192

Other funds holding BME

Comerica Bank's BME Position: Q4 2025 in Review

Comerica Bank reduced its BlackRock Health Sciences Trust (BME) stake by 2.6% in Q4 2025, selling an estimated $4.94K and leaving 4,682 shares worth $193K. The position accounts for ﹤0.01% of the portfolio, ranked #2316.

Comerica Bank first reported a position in BME in Q3 2023 and has held it in 10 quarters since. The position peaked at $220K in Q4 2023. 77 funds tracked by Wall St. Rank hold BME as of Q4 2025.

  • Comerica Bank held 4,682 shares of BlackRock Health Sciences Trust worth $193K as of Q4 2025.
  • Comerica Bank sold 125 BlackRock Health Sciences Trust shares in Q4 2025, an estimated $4.94K.
  • BlackRock Health Sciences Trust made up ﹤0.01% of Comerica Bank's portfolio in Q4 2025, its #2316 holding.
  • Comerica Bank first reported a position in BlackRock Health Sciences Trust in Q3 2023 and has held it in 10 quarters since.
  • Comerica Bank's BlackRock Health Sciences Trust position peaked at $220K in Q4 2023.
  • 77 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.